Protonix® IV for Injection – pantoprazole sodium
Wyeth-Ayerst Laboratories
Protonix IV, indicated for the short-term treatment (seven to 10 days) of gastroesophageal reflux disease, is the first intravenous proton pump inhibitor in the United States. Treatment with Protonix IV should be discontinued as soon as the patient is able to swallow oral formulations. (www.ahp.com)
COPYRIGHT 2001 Clinicians Publishing Group
COPYRIGHT 2001 Gale Group
